Revvity Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Revvity Inc trades at $154.72 (market cap $16.98B), while Vipshop Holdings Ltd - ADR trades at $12.98 (market cap $6.05B). The key difference: Revvity Inc is far larger — about 2.8× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.87%). Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| RVTY | VIPS | |
|---|---|---|
Market Cap | $16.98B | $6.05B |
Volume | 1,456,900 | 3,719,230 |
Sector | Health | Consumer Cyclical |
52-Week High | $157.36 | $20.29 |
52-Week Low | $82.26 | $12.09 |
Typical Hold Time | 12 Days | 49 Days |
Enterprise Value | $19.30B | $2.87B |
Dividend Yield | 0.18% | 4.87% |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $153.60, up 0.2% today and near its 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving average signals and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of a CE-IVDR-certified T1D screening kit in Europe (Business Wire, 2026-09-24) and the acquisition of Human Cell Design to expand metabolic disease research tools (Business Wire, 2026-09-09).
The outlook is positive, supported by earnings momentum, strategic acquisitions, and analyst optimism. However, the stock trades at a premium valuation with a P/E of 73.15, and near-term risks include margin pressures in China and rich valuation limiting upside beyond consensus targets. Revenue stability but slight profit margin compression in 2026 warrants monitoring.
Vipshop Holdings trades at $12.77, showing modest daily gains of 0.16%. The stock presents compelling valuation metrics with a P/E of 4.1 and P/S of 0.4, trading below book value. Recent earnings show mixed performance with Q2 2026 missing expectations, though profitability remains strong with 9.82% net margins. Technical indicators show a bullish overall signal while oscillators remain neutral, with key support at $12.
The investment case centers on deep valuation discounts and strong profitability metrics, though revenue stagnation and consumer headwinds present challenges. Analyst consensus targets $16.17, offering 27% upside potential. Key risks include Chinese consumer sentiment weakness and competitive pressures in the off-price retail sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →